<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_ULaval_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:ULaval/Design</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="navbar"><DIV class="wrapperRight"><A style="font-size:16px;" href="https://2018.igem.org/Team:ULaval">Home</A><DIV class="dropdown"><BUTTON class="dropbtn">Project
            </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:ULaval/Description"><SPAN class="textMargin">Description</SPAN></A><A href="https://2018.igem.org/Team:ULaval/Design"><SPAN class="textMargin">Design</SPAN></A><A href="https://2018.igem.org/Team:ULaval/Results"><SPAN class="textMargin">Results</SPAN></A><A class="lastElement" href="https://2018.igem.org/Team:ULaval/InterLab"><SPAN class="textMargin">Interlab</SPAN></A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Parts
            </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:ULaval/Parts"><SPAN class="textMargin">Overview</SPAN></A><A class="lastElement" href="https://2018.igem.org/Team:ULaval/Basic_Part"><SPAN class="textMargin">Basic Parts</SPAN></A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Notebook
            </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:ULaval/Notebook"><SPAN class="textMargin">Lab Journal</SPAN></A><A href="https://2018.igem.org/Team:ULaval/Experiments"><SPAN class="textMargin">Protocols</SPAN></A><A class="lastElement" href="https://2018.igem.org/Team:ULaval/Achievements"><SPAN class="textMargin">Achievements</SPAN></A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Human Practices
            </BUTTON><DIV class="dropdown-content"><A href="https://2018.igem.org/Team:ULaval/Human_Practices"><SPAN class="textMargin">Human Practices</SPAN></A><A href="https://2018.igem.org/Team:ULaval/Public_Engagement"><SPAN class="textMargin">Public Engagement</SPAN></A><A class="lastElement" href="https://2018.igem.org/Team:ULaval/Safety"><SPAN class="textMargin">Safety</SPAN></A></DIV></DIV><DIV class="dropdown"><BUTTON class="dropbtn">Team
            </BUTTON><DIV class="dropdown-content-right"><A href="https://2018.igem.org/Team:ULaval/Team"><SPAN class="textMargin">Team members</SPAN></A><A href="https://2018.igem.org/Team:ULaval/Attributions"><SPAN class="textMargin">Attributions</SPAN></A><A class="lastElement" href="https://2018.igem.org/Team:ULaval/Collaborations"><SPAN class="textMargin">Collaborations</SPAN></A></DIV></DIV></DIV></DIV><DIV class="textContainer"><DIV class="bigTitle">Design</DIV><DIV class="sectionDescription">
Our team intends to use <I>Saccharomyces cerevisiae</I> (<I>S. cerevisiae</I>) to produce adrenaline. We designed a two-plasmid system which harbors synthetic human cDNAs encoding the adrenaline enzymatic pathway. We explored how the insertion of this plasmid system into a strain of <I>S. cerevisiae</I> engineered to overproduce L-tyrosine<SUP>1</SUP> can be used for the biosynthesis of adrenaline. As dopamine and noradrenaline, two of the three metabolic intermediates of the adrenaline enzymatic pathway<SUP>2</SUP> as shown in <I>Figure 1</I>, are also of biomedical interest<SUP>3</SUP>, we intend to create three strains of <I>S. cerevisiae</I> producing dopamine, noradrenaline or adrenaline based on plasmid combination. 
<DIV class="figureDesign"><CENTER><SPAN style="font-size:14px;"><I>Figure 1.</I> The adrenaline enzymatic pathway<SUP>2</SUP>.</SPAN></CENTER></DIV>
In order to achieve that we will create three plasmids. The first plasmid, pRS31N-TH-LDDC, will carry the genes coding for the first two enzymes of the biosynthetic pathway, tyrosine hydroxylase and aromatic L-amino acid decarboxylase, and will hence allow for the production of dopamine when transformed into the optimised strain of <I>S. cerevisiae.</I> The second plasmid, pRS31H-DBH, will contain the gene coding for dopamine β-hydroxylase in order to produce noradrenaline when combined with the first plasmid. The last construct, pRS31H-DBH-PNMT, will carry both the genes coding for dopamine β-hydroxylase and phenylethanolamine N-methyltransferase. As shown in <I>Figure 2</I>, the combination of the first and the last plasmid will therefore allow for the production of adrenaline. To assure that both plasmids can be maintained within the yeast cells simultaneously, they will be engineered to harbour different resistance genes. The plasmid pRS31N-TH-LDDC will possess a nourseotricin (NatR) resistance gene, while the plasmids pRS31H-DBH and pRS31H-DBH-PNMT will harbour a hygromycin (hPhR) resistance gene.
 
Finally, all the products will be purified by HPLC using the reverse-phase analytical  column Primesep 200 by SIELC Technologies which is made for the efficient separation of catecholamines<SUP>4</SUP>. <DIV class="figureDesign"><CENTER><SPAN style="font-size:14px;"><I>Figure 2.</I> Workflow of our scientific approach.</SPAN></CENTER></DIV><DIV class="referenceTitle">References</DIV><DIV style="text-align:initial;font-size:14px;">
1. Gold, N. D. et al., 2015. Metabolic engineering of a tyrosine-overproducing yeast platform using targetedmetabolomics. <I>Microbial Cell Factories</I>, 14(73). 
2. Pocock, G., Richards, C. D. &amp; Richards, D. A., 2013. <I>Human Physiology</I>. Fourth ed. Oxford: Oxford University Press. 
3. Burchum, J. R. &amp; Rosenthal, L. D., 2016. <I>Lehne's Pharmacology for Nursing Care</I>. 9th ed. USA: Elsevier. 
4. SIELC Technologies, 2018. <I>HPLC Separation of Catecholamines</I>. [Online] 
Available at: <A href="http://www.sielc.com/Application-HPLC-Separation-of-Catecholamines.html">http://www.sielc.com/Application-HPLC-Separation-of-Catecholamines.html</A>
[Accessed 03 2018].
 </DIV></DIV></DIV></DIV><FOOTER><DIV class="containerRight"><DIV style="font-size:16px;float:right;">igem@bcm.ulaval.ca</DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></BODY></HTML>